Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution

Michael R. Drapp, CEO of the newly-formed nanoEdge Technologies, LLC
Michael R. Drapp, CEO of the newly-formed nanoEdge Technologies, LLC

Abstract:
Michael R. Drapp, a 34-year veteran of the high-technology industry, has formed nanoEdge™ Technologies, a business development and intellectual property management company focused on the emerging nanotechnology space. The company also plans to invest in promising technologies and act as a nanotechnology incubator.

Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution

Monterey, CA | Posted on December 1st, 2009

Michael R. Drapp, a 34-year veteran of the high-technology industry, has formed nanoEdge™ Technologies, a business development and intellectual property management company focused on the emerging nanotechnology space. The company also plans to invest in promising technologies and act as a nanotechnology incubator.

"Nanotechnology is the next great frontier: for technology, for industry, and for humanity as a whole," says Drapp. "This isn't hyperbole. Every previous technological shift has been limited to mankind's external environment. Nanotechnology will also invade our internal space. Our medical treatments, our food, our entertainment…even our very definition of "self" will be impacted. This next shift will redefine the current demarcation between technology and humanity.

"Consider the title of the recent National Science Foundation report: 'Ethics of Human Enhancement'. They are talking about the use of technology to reengineer humanity - what some would call eugenics. Does this raise ethical, legal and environmental issues? Absolutely.

"But this emerging 'nanosphere' also presents incredible opportunity. I formed nanoEdge™ Technologies because I've seen too much valuable IP die on the vine or get highjacked because the brilliant people who developed the science weren't focused on or perhaps skilled at maximizing the commercial potential of their ideas.

"It's not enough to give somebody in your company a business development title to promote the mousetrap you think you have in your hand. You have to be able to see the emerging opportunities and identify innovative ways to combine that mousetrap with other technologies to create entirely new products and markets. This requires a particular skillset and experience base that can conceptualize and execute across multiple disciplines and industries and connect dots that others aren't seeing yet.

"For example, a Middle Eastern company came to us looking for funding for their nano-camera and nano-sensor technologies. They didn't realize they had already been eclipsed in the applications they were targeting by a European technology. We were able to give them some innovative ideas for adding value to their product design and creating new applications in other industries. This will help them better focus their final stage R&D and reposition their go-to-market strategy for a successful launch.

"This is where nanoEdge™ excells at adding value. We have an exceptional track record of creating multiplied returns for clients from opportunities that they didn't know they had.

"This expertise is even more critical for nanotech companies because more often than not, the true value of their IP is not in a single product but rather in the application of their IP to other products, services and technologies - what I term 'nanosynergistics'. You can't leverage this kind of integrated value via a traditional in-house sales and marketing model. You need a bigger network and higher levels of access. And you have to be able to envision and execute across multiple disciplines and industries.

"Our goal at nanoEdge™ is to help our clients productize and commercialize their intellectual properties to maximum advantage. Licensing, technology transfer, reengineering and design, new product development, mergers or acquisitions, venture capital, joint ventures, strategic partnerships - we'll leverage our networks and whichever channels and strategies will produce the best business and financial outcomes for each client.

"I started my first technology company when I was 20 and I've ridden a lot of market waves up and down over the years. But when I look out at the emerging nanospace and the technologies that are now in the lab or getting ready to launch, I can't see an end to this new wave - to the potential applications and their impacts. I can't think of an industry or area of life that won't be affected.

"And I can't think of anywhere else I'd rather invest than right here - on the 'nanoEdge' of the next technology revolution."

####

About nanoEdge™ Technologies
nanoEdge™ Technologies is a business development and intellectual property management company focused on emerging nanotechnologies and related applications. The company’s interdisciplinary approach combines hands-on expertise in operations, engineering and design, sales and marketing, and cash flow management with proven strategies for successfully identifying, productizing and commercializing new technologies in diverse market environments. For additional information on the company’s services, contact Linda Cavalli at or visit www.nanoedgetech.com. You can also follow Mr. Drapp’s musings on the emerging “nanosphere” on his new blog, (www.thenanoedge.com) and on Twitter (thenanoedge).

About Michael R. Drapp

Mr. Drapp has a track record of forecasting and leveraging emerging market and technology trends. His visionary 'outside-of-the-box' opportunity analysis and business execution have resulted in triple-digit revenue growth for the companies he has founded or worked for. In addition to executive-level experience with companies that include Fujitsu, Hitachi, Wang, Xerox and Hewlett-Packard, Mr. Drapp has served as CEO and founder of seven companies that have produced over a billion dollars in aggregate global revenue.

For more information, please click here

Copyright © PRWeb

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Investments/IPO's/Splits

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Announcements

Berkeley Lab Researchers Demonstrate First Size-based Chromatography Technique for the Study of Living Cells April 22nd, 2014

PETA science consortium to present hazard testing strategy at nanotoxicology meeting: High tech field ripe for use of sophisticated non-animal testing strategies April 22nd, 2014

Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014

National Space Society Congratulates SpaceX on the Success of CRS-3 and the First Flight of the Falcon 9R April 22nd, 2014

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Nanoparticles cause cancer cells to self-destruct April 3rd, 2014

A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014

Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE